Insmed (INSM) Cash from Operations (2010 - 2026)
Insmed's (INSM) quarterly Cash from Operations came in at 222738000.0 in Q1 2026, up 15.01% year-on-year from 193661572.01 in Q1 2025, and up 10.04% quarter-over-quarter from 247596000.0 in Q4 2025.
Insmed (INSM) Cash from Operations (2010 - 2026) Analysis & Trends
Insmed's Cash from Operations history runs 17 years deep, the most recent figure standing at 222738000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 15.01% year-over-year to 222738000.0 in Q1 2026; TTM through Mar 2026 was 895664000.0, a 17.55% decrease from a year earlier, with the FY2025 full-year figure at 935014000.0, down 36.72% from the prior year.
- Cash from Operations improved to 222738000.0 in Q1 2026 per INSM's latest filing, from 247596000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 89828000.0 in Q3 2022 and bottomed at 262088000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 146303000.0 (2023), against an average of 163430588.24.
- Across the five-year window, Cash from Operations climbed 18.02% in 2022 and tumbled 67.19% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 103149000.0 in 2022, then fell by 26.83% to 130819000.0 in 2023, then slumped by 49.81% to 195979000.0 in 2024, then declined by 26.34% to 247596000.0 in 2025, then gained by 10.04% to 222738000.0 in 2026.
- Per Business Quant, the three latest INSM Cash from Operations figures stand at 222738000.0 (Q1 2026), 247596000.0 (Q4 2025), and 219761000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -222.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -222.74 Mn |
| Mar 31, 2026 | -222.74 Mn |
| Dec 31, 2025 | -247.60 Mn |
| Dec 31, 2025 | -247.60 Mn |
| Sep 30, 2025 | -219.76 Mn |
| Sep 30, 2025 | -219.76 Mn |
| Jun 30, 2025 | -205.57 Mn |
| Jun 30, 2025 | -205.57 Mn |
| Mar 31, 2025 | -262.09 Mn |
| Mar 31, 2025 | -262.09 Mn |
| Dec 31, 2024 | -195.98 Mn |
| Dec 31, 2024 | -195.98 Mn |
| Sep 30, 2024 | -180.92 Mn |
| Sep 30, 2024 | -180.92 Mn |
| Jun 30, 2024 | -122.95 Mn |
| Jun 30, 2024 | -122.95 Mn |
| Mar 31, 2024 | -184.04 Mn |
| Mar 31, 2024 | -184.04 Mn |
| Dec 31, 2023 | -130.82 Mn |
| Dec 31, 2023 | -130.82 Mn |